DVA

NEUTRALEarnings

DaVita Inc.

2026-07-21

Price

$237.28

+1.36%

This is the 2026-07-21 snapshot — the signals and analysis for DVA as of this single trading day.

View full DVA research hub →

Score6.0Priority

Signals3/8 DNA0/13 Act · 0/4 Risk

SentimentNEUTRALScore: 8

Volume0.7xvs 20d avg

Analysis

DVA is undergoing High-Conviction Price Discovery as institutional buyers position aggressively ahead of its August 4th Q2 earnings report. Recent analyst upgrades from Truist and UBS, which lifted price targets to the $250-$270 range, underscore growing confidence in the company's treatment volume recovery and AI-driven operational efficiencies. Supported by a RISK_ON macro regime with tight credit spreads and muted volatility, these pristine technical signals (ALPHA_MALE, PERFECT_STACK) confirm that the market is entirely focused on DVA's fundamental outperformance rather than headline geopolitical noise.

Fired Signals

ALPHA MALEGOLDEN CROSSPERFECT STACK

Key Takeaways

Actionable Thesis: Accumulate DVA to capture pre-earnings momentum, backed by strong relative strength (+12.6% vs SPY) and institutional accumulation signals.
Key Risk: Elevated expectations following Q1's massive beat mean any weakness in Q2 operating margins or conservative forward guidance could trigger swift profit-taking.
What to Watch: Monitor the $210.93 technical line-in-the-sand and the August 4th earnings print for confirmation of sustained volume growth.

← Back to 2026-07-21 View Full DVA History →Yahoo Finance &nearr;